Young people most at risk of rare blood clots after AstraZeneca vaccine
Published
Younger adults are most at risk of rare blood clotting after having the Oxford-AstraZeneca vaccine, the UK’s medicines regulator has said.
Full ArticlePublished
Younger adults are most at risk of rare blood clotting after having the Oxford-AstraZeneca vaccine, the UK’s medicines regulator has said.
Full ArticleLONDON (AP) — AstraZeneca says it delivered about 68 million doses of its COVID-19 vaccine during the first three months of 2021..
SAN FRANCISCO (AP) — A San Francisco Bay Area man in his 30s is recuperating after developing a rare blood clot in his leg within..